Drug-labels.com

Reddy-Bosutinib: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
100 mg, 400 mg, 500 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Reddy-Bosutinib

Serious Warnings and Precautions

Serious side effects with Reddy–Bosutinib include:

  • Drug interactions with inhibitors or inducers of CYP3A4 enzyme. Do NOT use Reddy–Bosutinib with strong and moderate CYP3A4 inhibitors and inducers (see Serious Drug and Drug-Food Interactions below)
  • Gastrointestinal problems (vomiting and diarrhea)
  • Liver problems
  • Heart problems that may lead to death
  • Fluid in the lungs and around the heart (fluid retention)
  • Bleeding
  • Abnormal electrical signal of the heart

What is Reddy–Bosutinib used for?

Reddy–Bosutinib is used to treat adults:

  • who have a new diagnosis of a white blood cell cancer called Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in a chronic phase or
  • who have Ph+ CML in a chronic, accelerated, or blast phase (the blood cancer grows faster in accelerated or blast than in chronic phase) and for whom previous medicines to treat Ph+ CML have either not worked or not been suitable.

A qualified healthcare professional experienced in the use of anticancer therapies and in the treatment of CML should prescribe Reddy–Bosutinib.

Reddy–Bosutinib is NOT recommended for use in children less than 18 years of age.

How does Reddy–Bosutinib work?

Reddy–Bosutinib works by slowing down the growth and spread of cancer cells in patients with CML.

What are the ingredients in Reddy–Bosutinib?

Medicinal ingredients: bosutinib

Non-medicinal ingredients: crospovidone, magnesium stearate, microcrystalline cellulose, opadry brown (500 mg), opadry orange (400 mg), opadry yellow (100 mg), poloxamer, povidone.

Colorants: hypromellose, iron oxide red (400 mg and 500 mg), iron oxide yellow (100 mg and 400 mg), polyethylene glycol, talc (500 mg) and titanium dioxide.

Reddy–Bosutinib comes in the following dosage forms:

Tablets: 100 mg, 400 mg, and 500 mg

Do not use Reddy–Bosutinib if you:

  • are allergic to bosutinib or any of the other ingredients of Reddy–Bosutinib
  • have an abnormal electrical signal of the heart (prolongation of QT interval)
  • have uncorrectable low levels of potassium or magnesium
  • have liver problems (such as liver failure)

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take Reddy–Bosutinib. Talk about any health conditions or problems you may have, including if you:

  • have or have had a liver problem.
  • have or have had a heart problem.
  • have or have had a pancreas problem.
  • have or have had a kidney problem.
  • have gastrointestinal problems (vomiting and diarrhea).
  • have or have had in the past, a hepatitis B virus infection (a viral infection of the liver). This is because during treatment with Reddy–Bosutinib, hepatitis B may become active again which can lead to death in some cases. Your doctor will test for signs of this infection before treatment with Reddy–Bosutinib and while on treatment if required.

Other warnings you should know about:

Female patients:

Pregnancy and birth control

  • If you are pregnant or plan to become pregnant, there are specific risks you should discuss with your healthcare professional.
  • Do NOT become pregnant while taking Reddy–Bosutinib. It may cause harm to your unborn child.
  • Use highly effective birth control during treatment and for at least one month after your last dose of Reddy–Bosutinib.
  • Tell your healthcare professional right away if you become pregnant.

Breast-feeding

  • Reddy–Bosutinib may pass into your breast milk and harm your baby.
  • Do NOT breast-feed during treatment with Reddy–Bosutinib.
  • Talk to your healthcare professional about the best way to feed your baby during treatment with Reddy–Bosutinib.

Male patients:

  • Use highly effective birth control each time you have sex with a woman who is pregnant, may be pregnant or could become pregnant. Continue using birth control for at least 4 weeks after the last dose of Reddy–Bosutinib.
  • Tell your healthcare professional right away if your sexual partner becomes pregnant.

Fertility:

Treatment with Reddy–Bosutinib may affect your ability to have children in both male and female patients. Talk to your healthcare professional if this is a concern for you.

Driving and using machines:

Before engaging in tasks that require special attention, wait until you know how you respond to Reddy–Bosutinib. Do NOT drive or use machines if you feel tired, dizzy, or experience any changes in vision while taking Reddy–Bosutinib.

Monitoring and laboratory tests:

Your healthcare professional will regularly monitor and assess your health before and while you are taking Reddy–Bosutinib. This may include blood tests, urine tests and ECG recording.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

Serious Drug and Drug-Food Interactions

Do NOT take any products or juice containing grapefruit, star fruit, pomegranate, Seville oranges or similar fruits while taking Reddy–Bosutinib. They may change the amount of Reddy–Bosutinib in your body.

While taking Reddy–Bosutinib, avoid taking drugs that are used to:

  • treat fungal infections such as ketoconazole, itraconazole, voriconazole, posaconazole, and fluconazole
  • treat human immunodeficiency virus (HIV) infections such as lopinavir/ritonavir, atazanavir, indinavir, nelfinavir, saquinavir, darunavir/ritonavir, amprenavir, efavirenz, etravirine and fosamprenavir.
  • treat high blood pressure such as dialtiazem, verapamil, bosentan and mibefradil
  • treat depression such as nefazodone and St. John’s wort (a herbal preparation obtained without a prescription)
  • treat bacterial infections such as erythromycin, clarithromycin, ciprofloxacin and nafcillin
  • treat tuberculosis such as rifampicin
  • treat epilepsy such as phenytoin and carbamazepine
  • prevent and control nausea (feeling sick) and vomiting, such as aprepitant
  • treat certain types of sleep disorders, such as modafinil
  • treat cancers, such as crizotinib and imatinib
  • treat hepatitis C virus, such as telaprevir
  • treat low sodium, such as conivaptan

The following may also interact with Reddy–Bosutinib:

  • Vandetanib, sunitinib, nilotinib, lapatinib (other cancer medicines).
  • Quinidine, amiodarone and other medicines for heart rhythm problems (anti-arrhythmic medicines).
  • Lansoprazole, dexlansoprazole, omeprazole, esomeprazole, pantoprazole, rabeprazole (medicines for reducing stomach acid).
  • Amitryptiline and imipramine (medicine for depression).
  • Pimozide, ziprasidone, haloperidol (medicine for psychoses).
  • Quinine and chloroquine (medicine to treat malaria).
  • Domperidone, dolasetron and ondansetron (medicine for nausea and vomiting).
  • Formoterol and salmeterol (asthma medicines).
  • Water pills, laxatives (medicine that decrease electrolyte levels).

Know the medicines you take. Keep a list of your medicines, both prescription and non-prescription, and show it to your doctor and pharmacist when you get a new medicine. Do NOT take other medicines with Reddy–Bosutinib until you have discussed with your doctor.

How to take Reddy–Bosutinib:

  • Always take Reddy–Bosutinib exactly as your healthcare professional has told you. Check with your doctor or pharmacist if you are not sure.
  • Reddy–Bosutinib should be taken with a meal.
  • Swallow Reddy–Bosutinib tablets whole. Do NOT cut, crush or dissolve the tablets.
  • Do NOT drink grapefruit juice or eat grapefruit, grapefruit products, star fruit, pomegranate, Seville oranges and other similar fruits. They may change the amount of Reddy–Bosutinib in your body.

Usual dose:

Adults (18 years of age and older)

  • Patients with newly-diagnosed chronic phase Ph+ CML: 400 mg once daily.
  • Patients with chronic, accelerated, or blast phase Ph+ CML whose previous medicines to treat Ph+CML have either not worked or not been suitable: 500 mg once daily.

Your healthcare professional will monitor your health during treatment with Reddy–Bosutinib. They may interrupt, change, or stop your dose. This may occur based on your current health, or if you experience certain side effects.

Overdose:

If you think you have, or a person you are caring for, taken too much Reddy–Bosutinib, contact a healthcare professional, hospital emergency department, or regional poison control centre or Health Canada’s toll-free number, 1-844 POISON-X (1-844-764-7669) immediately, even if there are no symptoms.

If possible, show your healthcare professional the blister pack, or this leaflet. You may require medical attention.

Missed Dose:

If dose is missed by:

  • Less than 12 hours, take your recommended dose.
  • More than 12 hours, take your next dose at your regular time on the following day. Do not take a double dose to make up for the forgotten tablets.

What are possible side effects from using Reddy–Bosutinib?

These are not all the possible side effects that you may have when taking Reddy–Bosutinib. If you experience any side effects not listed here, tell your healthcare professional.

Side effects include:

  • Rash
  • Nasopharyngitis (common cold virus): sore throat combined with runny nose
  • Back pain
  • Dysgeusia (altered taste perception): persistent foul, salty, rancid, or metallic taste sensation in the mouth
  • Gastrointestinal toxicity: diarrhea, vomiting, stomach pain, nausea, and/or decrease of appetite
  • Gastritis (stomach inflammation): stomach irritation
  • Arthralgia (Joint pain): mild to severe pain, limited joint motion, locking of the joint, stiffness
  • Fatigue
  • Headache
  • Dizziness
  • Fever
  • Influenza (viral infection that affects the respiratory system): fever, body aches, fatigue
  • Bronchitis (inflammation of the bronchial tubes): cough, chest tightness, wheezing
  • Dehydration (excessive loss of body fluid)
  • Itching, urticaria (hives), acne (conditions affecting the skin)

Tell your doctor if you have any side effect that bothers you or that does not go away.

Serious side effects and what to do about them

Serious side effects and what to do about them
Serious side effects and what to do about them
Serious side effects and what to do about them
Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking this drug and get immediate medical help
Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking this drug and get immediate medical help
Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking this drug and get immediate medical help
Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking this drug and get immediate medical help
Only if severeIn all cases
Only if severeIn all cases
Only if severeIn all cases
Only if severeIn all cases
VERY COMMON
Myelosuppression (decrease in bone marrow activity resulting in fewer red blood cells, white blood cells, and platelets): fatigue, shortness of breath, dizziness, weakness, rapid breathing, headache, bleeding, infections, and skin pallor✓
Dyspnea (difficulty breathing): shortness of breath, chest tightness✓
Changes in biochemical markers: used to determine if Reddy–Bosutinib is affecting your liver, kidney, and/or pancreas (shown in test results)✓

Pleural effusion (fluid around the

lungs): cough, shortness of breath,

elevated respiration rate, and

chest pain, heaviness, or tightness

✓
Neutropenia (abnormally low number of neutrophils [a type of white blood cell] in the blood): fever, chills or sweating, sore throat, mouth sores, infections, cough, and difficulty breathing✓

Edema (fluid retention): Swelling

of hands, feet or face

✓
COMMON✓

Hypertension (high blood

pressure): headache, nosebleed,

fatigue or confusion, vision

problems, shortness of breath,

chest pain, difficulty breathing, and

irregular heartbeat

✓

Cardiac Failure (heart doesn't

pump blood as efficiently as it

should) shortness of breath,

persistent cough, fatigue, nausea,

dizziness, swelling of lower

extremities, and rapid or irregular

heartbeat.

✓

Cardiac Ischemic events (heart

problems caused by narrowing of

arteries that supply blood to the

heart) Neck or jaw pain, shoulder

or arm pain, chest pain or

discomfort, rapid heartbeat,

shortness of breath during physical

activity, nausea, vomiting,

✓
sweating, and fatigue.

Pancreatitis (inflammation of the

pancreas): upper abdominal pain,

fever, rapid heart beat, nausea,

vomiting, tenderness when

touching the abdomen

✓

Pericardial effusion (accumulation

of fluid around the heart): chest

pain or discomfort, fainting,

shortness of breath, nausea,

elevated heart rate, elevated

breathing rate, swelling of upper

and lower extremities, pain in

upper right abdomen

✓
Renal failure, renal impairment (kidney failure, kidney impairment): decreased urine output, fluid retention, swelling of upper and lower extremities, shortness of breath, fatigue, nausea, weakness, and irregular heartbeat✓
Hepatotoxicity (liver injury or impairment of liver function): jaundice, abdominal pain in upper right abdomen, fatigue, loss of appetite, nausea, vomiting, rash, fever, weight loss, itching, and dark-coloured urine✓
Pneumonia (inflammation of the lungs caused by infection): cough which may produce green, yellow or bloody mucus, fever, chills, and difficulty breathing, shortness of breath, rapid, shallow breathing, chest pain that worsens with deep breathing or coughing, and fatigue✓
Hyperkalemia (abnormally high level of potassium in the blood): abdominal pain, diarrhea, chest pain, abnormal heartbeat, nausea, vomiting, and muscle weakness or numbness✓
Hypophosphatemia (abnormally lows level of phosphorous in the blood): muscle weakness, fatigue, bone pain and fractures, numbness, confusion, respiratory failure, heart failure, seizures, and coma✓
Respiratory failure (lack of oxygenated blood leading to respiratory failure): dizziness, difficulty breathing or shortness of breath, rapid breathing, fatigue,✓
elevated heart rate, wheezing, and cyanosis
Pulmonary hypertension (high blood pressure in the blood vessels leading from the heart to the lungs): shortness of breath, dizziness, chest pain/pressure, irregular heartbeat, fatigue, swelling in the upper and lower extremities, and cyanosis✓

Gastrointestinal hemorrhage

(bleeding in the stomach or

intestine): black, tarry, or bright

red stool, blood in vomit,

abdominal cramps, dizziness,

fatigue, skin pallor, shortness of

breath, and weakness

✓

Long QT syndrome (abnormal

heartbeat): dizziness, heart

palpitations, loss of consciousness,

cardiac arrest, and seizures

✓
UNCOMMON

Pericarditis (inflammation of the

sac-like structure surrounding the

heart): chest pain, cough, elevated

heart rate, irregular heart rate,

fever, shortness of breath,

weakness, and fatigue

✓

Anaphylactic shock (severe

potentially life-threatening allergic

reaction): dizziness, difficulty breathing and shortness of breath,

rapid breathing, cyanosis, nausea

or vomiting, elevated heart rate,

tongue swelling, difficulty

swallowing, facial swelling, and

confusion

✓
Erythema multiforme (severe inflammatory skin reaction): exfoliative (scaly, peeling) skin eruptions, fever, headache, mouth sores, fatigue, pruritus, and joint pain✓

Interstitial lung disease (disorders

causing scarring in the lungs):

Cough, difficulty breathing, painful

breathing

✓

Bone fracture (broken bone): area

around break will be painful and

swollen, bulge or bump at site of

✓
break
RARE
Stevens-Johnson syndrome (severe skin reaction): fever, sore mouth/throat, cough, muscle aches, pruritus, severe red rash that blisters/peels with mouth sores and painful, red, watery eyes✓
UNKNOWN FREQUENCY

Hepatitis B (liver infection) virus

reactivation: this occurs when a previous hepatitis B infection becomes active again, which can be fatal in some cases. Symptoms include jaundice, abdominal pain in upper right abdomen, fatigue, loss of appetite, nausea, vomiting, rash, fever, weight loss, itching, and dark-coloured urine

✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting side effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (canada.ca/drug-device-reporting) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store at 20°C to 25°C.

Keep out of the reach and sight of children.

If you want more information about Reddy–Bosutinib:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this

    • Patient Medication Information by visiting the Health Canada website (Drug Product Database: Access the database); the manufacturer’s website www.drreddys.com, or

by calling 1-855-845- 1739.

Last Revised: 2025-08-11

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02560038

Revision date stated in the text: August 11, 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Reddy-Bosutinib

Rx or OTC
Prescription (Rx)?
DIN 02560038, 02560011, 02560046
Schedule(s) PRESCRIPTION
Active ingredient(s) Bosutinib (bosutinib dihydrate)
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. L Antineoplastic and immunomodulating agents
    1. L01 Antineoplastic agents
      1. L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents
        1. L01EA BCR-ABL tyrosine kinase inhibitors
          1. L01EA04 Bosutinib
Company DR REDDY'S LABORATORIES LTD
Strengths and forms
DIN Strength Dosage form(s) Current status
02560038 100 MG Tablet Marketed September 8, 2025
02560011 400 MG Tablet Approved August 11, 2025
02560046 500 MG Tablet Marketed September 8, 2025

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.